BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19290668)

  • 1. In vitro activity of the EWS oncogene transcriptional activation domain.
    Ng KP; Li KK; Lee KA
    Biochemistry; 2009 Apr; 48(13):2849-57. PubMed ID: 19290668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene.
    Zhou H; Lee KA
    Oncogene; 2001 Mar; 20(12):1519-24. PubMed ID: 11313895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcription assay for EWS oncoproteins in Xenopus oocytes.
    Ng KP; Cheung F; Lee KA
    Protein Cell; 2010 Oct; 1(10):927-34. PubMed ID: 21204019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene.
    Feng L; Lee KA
    Oncogene; 2001 Jul; 20(31):4161-8. PubMed ID: 11464282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly.
    Pan S; Ming KY; Dunn TA; Li KK; Lee KA
    Oncogene; 1998 Mar; 16(12):1625-31. PubMed ID: 9569031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
    Lee J; Rhee BK; Bae GY; Han YM; Kim J
    Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disordered binding regions of Ewing's sarcoma fusion proteins.
    Todorova R
    Bioorg Khim; 2014; 40(1):20-30. PubMed ID: 25898720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.
    Ng KP; Potikyan G; Savene RO; Denny CT; Uversky VN; Lee KA
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):479-84. PubMed ID: 17202261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ewing's sarcoma gene product functions as a transcriptional activator.
    Rossow KL; Janknecht R
    Cancer Res; 2001 Mar; 61(6):2690-5. PubMed ID: 11289149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the nuclear localization/retention signal in the EWS proto-oncoprotein.
    Zakaryan RP; Gehring H
    J Mol Biol; 2006 Oct; 363(1):27-38. PubMed ID: 16965792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
    Laflamme C; Filion C; Bridge JA; Ladanyi M; Goldring MB; Labelle Y
    Cancer Res; 2003 Jan; 63(2):449-54. PubMed ID: 12543801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ewings family oncoproteins: drunk, disorderly and in search of partners.
    Lee KA
    Cell Res; 2007 Apr; 17(4):286-8. PubMed ID: 17426699
    [No Abstract]   [Full Text] [Related]  

  • 13. RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains.
    Alex D; Lee KA
    Nucleic Acids Res; 2005; 33(4):1323-31. PubMed ID: 15743974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular recognition by the EWS transcriptional activation domain.
    Lee KA
    Adv Exp Med Biol; 2012; 725():106-25. PubMed ID: 22399321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLS, EWS and TAF15: a model for transcriptional integration of gene expression.
    Law WJ; Cann KL; Hicks GG
    Brief Funct Genomic Proteomic; 2006 Mar; 5(1):8-14. PubMed ID: 16769671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain.
    Li KK; Lee KA
    J Biol Chem; 2000 Jul; 275(30):23053-8. PubMed ID: 10767297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EWS-Oct-4 fusion gene encodes a transforming gene.
    Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
    Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism.
    Anumanthan G; Halder SK; Friedman DB; Datta PK
    Cancer Res; 2006 Nov; 66(22):10824-32. PubMed ID: 17108118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
    Coles EG; Lawlor ER; Bronner-Fraser M
    Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.